Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
6.65
-0.20 (-2.92%)
Aug 15, 2025, 4:00 PM - Market closed
Exicure Market Cap
Exicure has a market cap or net worth of $42.01 million as of August 15, 2025. Its market cap has increased by 1,008.51% in one year.
Market Cap
42.01M
Enterprise Value
34.16M
1-Year Change
1,008.51%
Ranking
Category
Stock Price
$6.65
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.31M to $42.01M, a decrease of -65.65%. That is a compound annual growth rate of -13.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 42.01M | 1.13% |
| Dec 31, 2024 | 41.54M | 727.79% |
| Dec 29, 2023 | 5.02M | -12.10% |
| Dec 30, 2022 | 5.71M | -72.06% |
| Dec 31, 2021 | 20.44M | -86.82% |
| Dec 31, 2020 | 155.05M | -37.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |